Products
CE Global Private Equity offers a wide range of investment products and services for retail and corporate investors.
Investment Performance Case Study
Jin Medical International Ltd.
Welcome to the Investment Performance Case Study of Jin Medical International Ltd. , which follows our clients' journeys of investing in Jin Medical International Ltd. between 28th Mar, 2023 and 16th Feb, 2024, during which the recorded share price produced a decline of 89%.
NASDAQ:ZJYL
Introduction
Jin Medical is a Chinese manufacturer of wheelchairs and other mobility aids, catering to individuals with disabilities, the elderly, and those recovering from injuries. The company focuses primarily on wheelchairs, which constitute the majority of its revenue.
The Jin Medical International Ltd. Investment Case
Jin Medical International is a manufacturer of rehabilitation and mobility products, including wheelchairs and related medical equipment. The company entered the US public markets in March 2023 through a Nasdaq initial public offering.
The Transaction
Jin Medical began public trading on 28 March 2023 with a study entry price of $8.00 per share.
Investment Outcome
By 16 February 2024, the study records an outcome value of $0.89 per share. This represents a decline of approximately 88.9% from the study entry price. Its inclusion provides an important counterpoint to the stronger-performing transactions within the wider case-study portfolio and demonstrates that public-market investments can result in substantial losses as well as gains.
- Event: Initial Public Offering
- Exchange: Nasdaq
- Study Period: 28 March 2023 – 16 February 2024
- Entry Price: $8.00
- Outcome Price: $0.89
Case Overview
| Company Name : | Jin Medical International Ltd. |
|---|---|
| Sector : | Medical |
| Event Type : | IPO |
| Buy Advice : | 2023-03-28 |
| Sell Advice : | 2024-02-16 |
| Buy Price : | 8.00 (USD) |
| Sell Price : | 0.89 (USD) |
| Profit(%) : | -89% |
Case Studies
